Adenine Deoxy Nucleoside

Also known as: Adenine Deoxyribonucleoside Adenine Deoxyribose Adenine Nucleoside Adenine Riboside Adenosine Adenyldeoxyriboside Deoxyadenosine Desoxyadenosine

Active ingredient description

Adenosine is a purine nucleoside which is present in all cells of the body. Animal pharmacology studies have in several species shown that adenosine has a negative dromotropic effect on the atrioventricular (AV) node.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
C01EB10
Adenosine
C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB10

Medicines

Adenine Deoxy Nucleoside is the active ingredient of these drugs:

Drug
Countries
ADENOCARD

Brazil Canada United States

ADENOCOR

Ireland Lithuania Netherlands Singapore Spain

ADENOSCAN

France Hong Kong Spain United Kingdom

ADREKAR

Lithuania

ATEPADENE

France Tunisia

ATEPODIN

Spain

KRENOSIN

France

LOWE

Brazil

STRIADYNE

France

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
ADENOCARD Solution for injection
Structured product labeling (SPL)
US
ADENOSCAN Solution for infusion
Summary of product characteristics (SPC)
UK
ADENOCOR Solution for injection
Summary of product characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

K72T3FS567 - ADENOSINE

CAS registry number

58-61-7 - Adenosine

SNOMED-CT

35431001 - Adenosine (substance)

Next: Usage